Unicharm (OTCMKTS:UNICY – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.04 earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Unicharm had a net margin of 6.33% and a return on equity of 6.85%.
Unicharm Price Performance
Unicharm stock traded up $0.26 during mid-day trading on Thursday, reaching $3.11. The company had a trading volume of 41,458 shares, compared to its average volume of 422,549. The stock’s 50-day simple moving average is $2.92 and its 200-day simple moving average is $3.01. Unicharm has a 1 year low of $2.61 and a 1 year high of $3.67. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.57 and a quick ratio of 2.06. The company has a market capitalization of $10.82 billion, a P/E ratio of 25.92 and a beta of 0.31.
Wall Street Analysts Forecast Growth
Separately, Zacks Research lowered shares of Unicharm from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy”.
Unicharm Company Profile
Unicharm Corporation is a Tokyo‐based consumer goods company founded in 1961. Specializing in hygiene and care products, the firm has built its reputation on developing innovative, high-performance solutions for everyday needs. Over more than six decades, Unicharm has grown from a domestic manufacturer to a leading global player in the personal care industry.
The company’s core business activities encompass the design, production and marketing of disposable hygiene products. Key product lines include baby care items such as diapers and training pants; feminine hygiene products including sanitary napkins and panty liners; adult incontinence solutions; and pet care offerings like pet diapers and wet wipes.
Featured Articles
- Five stocks we like better than Unicharm
- McDonald’s Stock Sell-Off: Justified Warning or Buying Opportunity?
- Why Brown-Forman Rejected a 23% Premium Twice
- Rocket Lab Lands a Wave of Contracts Ahead of Earnings
- Amprius Technologies Validates Growth Trajectory With Q2 Earnings—What Comes Next?
Receive News & Ratings for Unicharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unicharm and related companies with MarketBeat.com's FREE daily email newsletter.
